ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EDEN Eden Research Plc

4.55
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.55 4.30 4.80 4.55 4.55 4.55 496,424 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.83 24.27M

Eden Research plc Grant of Awards under Long-Term Incentive Plan (2102U)

01/04/2021 7:00am

UK Regulatory


Eden Research (LSE:EDEN)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Eden Research Charts.

TIDMEDEN

RNS Number : 2102U

Eden Research plc

01 April 2021

1 April 2021

Eden Research plc

("Eden" or "Company)

Grant of Awards under Long-Term Incentive Plan

Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, confirms the grant of awards under the Company's revised Long Term Incentive Plan ("LTIP") to Sean Smith, Chief Executive Officer, and Alex Abrey, Chief Finance Officer (together the "Executives"), as follows:

In the announcement of the Company's fundraising on 28 February 2020, the Company stated that it would implement a new Long-Term Incentive Plan (LTIP) and replace options granted under the previous LTIP that are deemed a more appropriate scheme to incentivise management given the Company's stage of development. In line with that announcement, the Company has now granted replacement options over 10.5 million new Ordinary Shares in Eden, at a strike price of 6p each (being the placing price of the 2020 fundraise), in the amounts of 6 million awarded to Sean Smith and 4.5 million awarded to Alex Abrey.

As announced on 28 February 2020, the options will vest immediately and will lapse in three equal tranches in June 2022, June 2023 and June 2024. For the first five years following the grant of options, no shares arising from the exercise of these options may be sold unless the Company's prevailing share price is equal to or in excess of 10p.

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

For further information contact:

 
                                                www.edenresearch.com 
   Eden Research plc 
 Sean Smith 
  Alex Abrey                                    01285 359 555 
 
   Cenkos Securities plc (Nominated advisor 
   and broker) 
 Giles Balleny / Camilla Hume/ Mark Connelly 
  (corporate finance) 
  Michael Johnson (sales)                       020 7397 8900 
 
   Hawthorn Advisors (Financial PR) 
 Lorna Cobbett / Victoria Ainsworth             eden@hawthornadvisors.com 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Sean Smith 
---  -------------------------------------------------------------  -------------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                Chief Executive Officer 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Initial notification /Amendment                                Initial Notification 
---  -------------------------------------------------------------  -------------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Eden Research plc 
---  -------------------------------------------------------------  -------------------------------- 
 b)   LEI                                                            213800ZWTYTVQQSM3J85 
---  -------------------------------------------------------------  -------------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument    Ordinary shares of 1 pence each 
       Identification code 
 
                                                                      GB0001646941 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Nature of the transaction                                      Grant of options 
---  -------------------------------------------------------------  -------------------------------- 
 c)   Price(s) and volume(s)                                          Price(s)   Volume(s) 
                                                                      ---------  ---------- 
                                                                       6p         6,000,000 
                                                                      ---------  ---------- 
---  -------------------------------------------------------------  -------------------------------- 
 d)   Aggregated information 
       - Aggregated volume 
       - Price                                                         N/A 
---  -------------------------------------------------------------  -------------------------------- 
 e)   Date of the transaction                                        31 March 2021 
---  -------------------------------------------------------------  -------------------------------- 
 f)   Place of the transaction                                       Outside of trading venue 
---  -------------------------------------------------------------  -------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Alex Abrey 
---  -------------------------------------------------------------  -------------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                Chief Financial Officer 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Initial notification /Amendment                                Initial Notification 
---  -------------------------------------------------------------  -------------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                           Eden Research plc 
---  -------------------------------------------------------------  -------------------------------- 
 b)   LEI                                                            213800ZWTYTVQQSM3J85 
---  -------------------------------------------------------------  -------------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument    Ordinary shares of 1 pence each 
       Identification code 
 
                                                                      GB0001646941 
---  -------------------------------------------------------------  -------------------------------- 
 b)   Nature of the transaction                                      Grant of options 
---  -------------------------------------------------------------  -------------------------------- 
 c)   Price(s) and volume(s)                                          Price(s)   Volume(s) 
                                                                      ---------  ---------- 
                                                                       6p         4,500,000 
                                                                      ---------  ---------- 
---  -------------------------------------------------------------  -------------------------------- 
 d)   Aggregated information 
       - Aggregated volume 
       - Price                                                         N/A 
---  -------------------------------------------------------------  -------------------------------- 
 e)   Date of the transaction                                        31 March 2021 
---  -------------------------------------------------------------  -------------------------------- 
 f)   Place of the transaction                                       Outside of trading venue 
---  -------------------------------------------------------------  -------------------------------- 
 
 
 
 

Notes to Editors:

Eden Research is an AIM quoted company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden's Sustaine(R) encapsulation technology is used to harness the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with both natural and synthetic compounds to enhance their performance and ease-of-use. Sustaine microcapsules are naturally derived, plastic-free, biodegradable micro-spheres derived from yeast extract. It is one of the only viable, proven and immediately registerable solutions to the microplastics problem in formulations requiring encapsulation.

Eden has numerous patents and a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. Eden was admitted to trading on AIM in May 2012.

For more information about Eden, please visit: www.edenresearch.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSDDFWFEFSELD

(END) Dow Jones Newswires

April 01, 2021 02:00 ET (06:00 GMT)

1 Year Eden Research Chart

1 Year Eden Research Chart

1 Month Eden Research Chart

1 Month Eden Research Chart

Your Recent History

Delayed Upgrade Clock